Multiple Sclerosis Trial, Recruiting (ISRCTN45742963)

Multiple Sclerosis Trial, Recruiting ISRCTN45742963 Sponsor: Karl Landsteiner Institute for Interdisciplinary Research at the Rehabilitation Center Muenster Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — ISRCTN45742963 — Data sourced from the ISRCTN registry. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis (MS), regardless of the type of MS they have or their ethnic background
People who are 18 years of age or older
People whose main place of residence is in Tyrol
People who have an excellent level of German language ability
People whose MS-related disability falls within a standard scoring range used by doctors to measure MS (confirm with trial site)

Who may not be able to join:

People who have had an MS relapse (a flare-up of symptoms) within the 90 days before the study begins
People who are pregnant
People who have certain other serious health conditions alongside their MS, such as cancer, dementia, or other neurological or psychiatric illnesses

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from the ISRCTN registry. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 10 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: ISRCTN45742963

Sponsor: Karl Landsteiner Institute for Interdisciplinary Research at the Rehabilitation Center Muenster

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

More information: https://www.isrctn.com/ISRCTN45742963

Eligibility summary (AI generated)

Written by an AI model from the ISRCTN registry eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis (MS), regardless of the type of MS they have or their ethnic background
People who are 18 years of age or older
People whose main place of residence is in Tyrol
People who have an excellent level of German language ability
People whose MS-related disability falls within a standard scoring range used by doctors to measure MS (confirm with trial site)

Who may not be able to join:

People who have had an MS relapse (a flare-up of symptoms) within the 90 days before the study begins
People who are pregnant
People who have certain other serious health conditions alongside their MS, such as cancer, dementia, or other neurological or psychiatric illnesses

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from the ISRCTN registry via Voxsanity (data last synced 10 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Karl Landsteiner Institute for Interdisciplinary Research at the Rehabilitation Center Muenster

Registry

ISRCTN registry

Start date

1 February 2021

Est. completion

29 November 2027

Where this trial is recruiting

🇦🇹 Austria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from the ISRCTN registry: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ISRCTN ↗

Source: ISRCTN registry (isrctn.com), data processed 10 July 2026. ISRCTN metadata is CC0; contribution content is CC BY 4.0.